These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29179987)

  • 21. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
    Huang Z; Yang Q; Huang Z
    Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.
    Makondi PT; Chu CM; Wei PL; Chang YJ
    PLoS One; 2017; 12(7):e0180616. PubMed ID: 28749961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

  • 26. CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.
    Dai L; Song ZX; Wei DP; Zhang JD; Liang JQ; Wang BB; Ma WT; Li LY; Dang YL; Zhao L; Zhang LM; Zhao YM
    Adv Ther; 2021 Jun; 38(6):2973-2989. PubMed ID: 33881746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
    Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
    Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
    Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
    Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
    Chen J; Wang Z; Shen X; Cui X; Guo Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer.
    Qi Y; Qi H; Liu Z; He P; Li B
    J Comput Biol; 2019 Apr; 26(4):364-375. PubMed ID: 30810359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue.
    Zhang W; Gong W; Ai H; Tang J; Shen C
    Tumori; 2014; 100(3):338-45. PubMed ID: 25076248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Key Candidate Genes and Pathways in Colorectal Cancer by Integrated Bioinformatical Analysis.
    Guo Y; Bao Y; Ma M; Yang W
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis.
    Jia Z; Ai X; Sun F; Zang T; Guan Y; Gao F
    Tumori; 2015; 101(1):117-22. PubMed ID: 25702669
    [TBL] [Abstract][Full Text] [Related]  

  • 36.  CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
    Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
    Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
    Zhuang L; Yang Z; Meng Z
    Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mining and exploration of rehabilitation nursing targets for colorectal cancer.
    Li R; He J; Ni Z; Zhang J; Chi X; Kang C; Li Z; Li X
    Aging (Albany NY); 2024 Apr; 16(8):7022-7042. PubMed ID: 38637125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of differentially expressed genes and their upstream regulators in colorectal cancer.
    Liu HY; Zhang CJ
    Cancer Gene Ther; 2017 Jun; 24(6):244-250. PubMed ID: 28409560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.